SOPHiA Genetics partners with AstraZeneca on diagnostics
August 05, 2026 | 15:01
SOPHiA Genetics, listed on Nasdaq under ticker SOPH, entered a global collaboration with AstraZeneca to develop, validate and deploy two companion diagnostics supporting precision oncology therapies.
Mobile Version